5-chloromethyl-3-(2-fluoro-4-trifluoromethyl-phenyl)-isoxazole | 858938-93-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 5-chloromethyl-3-(2-fluoro-4-trifluoromethyl-phenyl)-isoxazole
• 英文别名: 5-(chloromethyl)-3-[2-fluoro-4-(trifluoromethyl)phenyl]-1,2-oxazole
• CAS: 858938-93-9
• 化学式: C₁₁H₆ClF₄NO
• 分子量: 279.621
• InChiKey: KJJWBNKNUGONLM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  18
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.18
• 拓扑面积：
  26
• 氢给体数：
  0
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  5-chloromethyl-3-(2-fluoro-4-trifluoromethyl-phenyl)-isoxazole 、 2-(2-氟苯基)-3H-咪唑并[4,5-c]吡啶 在 sodium hydroxide 作用下， 以 DMF (N,N-dimethyl-formamide) 、 水 为溶剂， 反应 5.0h， 生成 5-((3-(4-trifluoromethyl-2-fluorophenyl)isoxazol-5-yl)methyl)-2-(2-fluorophenyl)-5H-imidazo[4,5-c]pyridine
  参考文献：
  名称：

  [EN] IMIDAZO[4,5-c]PYRIDINE COMPOUNDS AND METHODS OF ANTIVIRAL TREATMENT
  [FR] COMPOSES D'IMIDAZO[4,5-C]PYRIDINE ET METHODES DE TRAITEMENT ANTIVIRAL

  摘要：

  公开号：

  WO2005063744A3
• 作为产物：
  描述：

  3-氯丙炔 、 2-Fluoro-4-trifluoromethyl-benzaldehyde oxime 在 sodium hypochlorite 作用下， 以 二氯甲烷 为溶剂， 反应 2.1h， 生成 5-chloromethyl-3-(2-fluoro-4-trifluoromethyl-phenyl)-isoxazole
  参考文献：
  名称：

  [EN] IMIDAZO[4,5-c]PYRIDINE COMPOUNDS AND METHODS OF ANTIVIRAL TREATMENT
  [FR] COMPOSES D'IMIDAZO[4,5-C]PYRIDINE ET METHODES DE TRAITEMENT ANTIVIRAL

  摘要：

  公开号：

  WO2005063744A3

文献信息

• Processes For The Preparation Of Anti-Viral Compounds And Compositions Containing Them
  申请人：Leivers Martin Robert

  公开号：US20100029655A1

  公开（公告）日：2010-02-04

  Disclosed are processes for the preparation of compounds of formula I and compositions that comprise said compounds of formula I. Also disclosed are processes for the preparation of compounds of formula III and compositions that comprise said compounds of formula III.

  公开了制备公式I化合物的过程以及包含所述公式I化合物的组合物。 还公开了制备公式III化合物的过程以及包含所述公式III化合物的组合物。
• [EN] ANTI-VIRAL COMPOUNDS, COMPOSITIONS, AND METHODS OF USE<br/>[FR] COMPOSÉS ANTIVIRAUX, COMPOSITIONS ET LEURS PROCÉDÉS D'UTILISATION
  申请人：GENELABS TECH INC

  公开号：WO2009011787A1

  公开（公告）日：2009-01-22

  Disclosed are compounds of Formula (I), pharmaceutically acceptable salts and solvates thereof, compositions thereof, and methods for their preparation and uses for treating viral infections mediated at least in part by a virus in the Flaviviridae family of viruses. (I)

  揭示了式（I）的化合物，其药用盐和溶剂化合物，以及其组合物，以及其制备方法和用于治疗至少部分由黄病毒科病毒介导的病毒感染的用途。
• [EN] PROCESSES FOR THE PREPARATION OF ANTI-VIRAL COMPOUNDS AND COMPOSITIONS CONTAINING THEM<br/>[FR] PROCÉDÉS DE PRÉPARATION DE COMPOSÉS ANTIVIRAUX ET COMPOSITIONS LES CONTENANT
  申请人：SMITHKLINE BEECHAM CORP

  公开号：WO2010006096A1

  公开（公告）日：2010-01-14

  Disclosed are processes for the preparation of compounds of formula I and compositions that comprise said compounds of formula I. See Formula I. Also disclosed are processes for the preparation of compounds of formula III and compositions that comprise said compounds of formula III. See Formula III.

  公开了制备式I化合物的过程和包含该式I化合物的组合物。请参见式I。还公开了制备式III化合物的过程和包含该式III化合物的组合物。请参见式III。
• Imidazo 4,5-C Pyridine Compounds and Methods of Antiviral Treatment
  申请人：Bondy S. Steven

  公开号：US20070244148A1

  公开（公告）日：2007-10-18

  The present invention relates to a pharmaceutical composition for the treatment or prevention of viral infections comprising as an active principle at least one imidazo[4,5-c]pyridine prodrug having the general formula (Z): The invention also relates to processes for the preparation of compounds according to the invention having above mentioned general formula and their use as a medicine or to treat or prevent viral infections.

  本发明涉及一种用于治疗或预防病毒感染的药物组合物，其包含至少一种具有以下通式（Z）的咪唑[4,5-c]吡啶前药作为活性成分：本发明还涉及制备符合上述通式的化合物的方法以及它们作为药物或用于治疗或预防病毒感染的用途。
• IMIDAZO[4,5-c]PYRIDINE COMPOUNDS AND METHODS OF ANTIVIRAL TREATMENT
  申请人：Bondy Steven S.

  公开号：US20100028301A1

  公开（公告）日：2010-02-04

  The present invention relates to pharmaceutical compositions for the treatment or prevention of viral infections comprising as an active principle at least one imidazo[4,5-c]pyridine prodrug having the general Formula (A) wherein the substituents are described in the specification. The invention also relates to processes for the preparation and screening of compounds according to the invention having above mentioned general Formula and their use in the treatment or prophylaxis of viral infections.

  本发明涉及一种制备用于治疗或预防病毒感染的药物组合物，其包含至少一种咪唑并[4,5-c]吡啶前药作为活性成分，其通式为（A），其中取代基在规范中描述。该发明还涉及根据上述通式制备和筛选化合物的方法以及它们在治疗或预防病毒感染中的应用。